METHODS FOR ASSESSING COMPLEMENT ACTIVATION IN THE CLINICAL IMMUNOLOGY LABORATORY

被引:21
作者
PORCEL, JM [1 ]
PEAKMAN, M [1 ]
SENALDI, G [1 ]
VERGANI, D [1 ]
机构
[1] KINGS COLL,SCH MED & DENT,DEPT IMMUNOL,BESSEMER RD,LONDON SE5 9PJ,ENGLAND
基金
英国惠康基金;
关键词
COMPLEMENT; COMPLEMENT ACTIVATION; SYSTEMIC LUPUS ERYTHEMATOSUS;
D O I
10.1016/0022-1759(93)90063-D
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Complement activation is a key component of the pathogenesis of immune-mediated tissue damage in many diseases. Assessment of complement activation in current practice is largely based on the measurement of intact C3 and C4 or the determination of complement haemolytic function. These parameters reflect activation only indirectly, are insensitive and open to influence by factors other than complement conversion. New approaches to evaluate complement activation directly using sensitive techniques have been developed, and several could be adopted easily in most laboratories. These concentrate on the detection of activation fragments, neoantigens or complexes that only arise as a direct result of complement activation. The wide application of these techniques in research and clinical practice would enhance our understanding of the pathogenesis of a range of inflammatory and infectious diseases.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 80 条
[1]   COMPUTER-ASSISTED KINETIC ASSAY FOR QUANTIFICATION OF TOTAL COMPLEMENT ACTIVITY [J].
ABBAL, M ;
TKACZUK, J ;
PRAUD, C ;
MSAYEH, F ;
OHAYON, E .
COMPLEMENT AND INFLAMMATION, 1991, 8 (02) :92-103
[2]  
ADELSBERG BR, 1985, DIAGN CLIN IMMUNOL, V3, P187
[3]   MONOCLONAL-ANTIBODIES AGAINST COMPLEMENT-3 NEOANTIGENS FOR DETECTION OF IMMUNE-COMPLEXES AND COMPLEMENT ACTIVATION - RELATIONSHIP BETWEEN IMMUNE-COMPLEX LEVELS, STATE OF C-3, AND NUMBERS OF RECEPTORS FOR C3B [J].
AGUADO, MT ;
LAMBRIS, JD ;
TSOKOS, GC ;
BURGER, R ;
BITTERSUERMANN, D ;
TAMERIUS, JD ;
DIXON, FJ ;
THEOFILOPOULOS, AN .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) :1418-1426
[4]   A NEW METHOD FOR THE ESTIMATION OF C3D - AFFINITY CLEARANCE OF C-DETERMINANT-BEARING C3-MOLECULES AND FRAGMENTS FOLLOWED BY ESTIMATION OF C3D BY ELISA [J].
ASGHAR, SS ;
SCHRAAG, B ;
BACKHAUS, AHL ;
ZORN, I ;
VENNEKER, GT ;
HANNEMA, AJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 120 (02) :207-214
[5]   COMPLEMENT ACTIVATION DURING SYSTEMIC LUPUS-ERYTHEMATOSUS - C3A AND C5A ANAPHYLATOXINS CIRCULATE DURING EXACERBATIONS OF DISEASE [J].
BELMONT, HM ;
HOPKINS, P ;
EDELSON, HS ;
KAPLAN, HB ;
LUDEWIG, R ;
WEISSMANN, G ;
ABRAMSON, S .
ARTHRITIS AND RHEUMATISM, 1986, 29 (09) :1085-1089
[6]   ACCUMULATION OF ANAPHYLATOXINS AND TERMINAL COMPLEMENT COMPLEXES IN INFLAMMATORY FLUIDS [J].
BENGTSSON, A ;
BENGTSON, JP ;
RYDENHAG, A ;
ROXVALL, L ;
HEIDEMAN, M .
JOURNAL OF INTERNAL MEDICINE, 1990, 228 (02) :173-176
[7]   A SIMPLE METHOD FOR QUANTITATIVE MEASUREMENT OF C3D IN HUMAN-PLASMA [J].
BHAKDI, S ;
ROTH, M ;
NURNBERGER, W .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 74 (01) :79-86
[8]   DEVELOPMENT AND EVALUATION OF A RAPID, SEMIAUTOMATIC MICROMETHOD FOR CH50 ESTIMATION USING A COMPUTER-PROGRAM [J].
BLANN, AD ;
LEWIN, I ;
BACON, PA .
IMMUNOLOGICAL INVESTIGATIONS, 1990, 19 (02) :109-118
[9]   DOUBLE-DECKER ROCKET IMMUNOELECTROPHORESIS FOR DIRECT QUANTITATION OF COMPLEMENT C-3 SPLIT PRODUCTS WITH C3D SPECIFICITIES IN PLASMA [J].
BRANDSLUND, I ;
SIERSTED, HC ;
SVEHAG, SE ;
TEISNER, B .
JOURNAL OF IMMUNOLOGICAL METHODS, 1981, 44 (01) :63-71
[10]  
BURGER R, 1988, J IMMUNOL, V141, P553